Five agonists that provide GLP-1 and glucagon receptor activity are in phase I/II of clinical development, of which only cotadutide and SAR425899 have shown substantial glycaemic efficacy
Avadel CNS Pharmaceuticals, LLC Food and Drug Law Institute (FDLI), accessed February 26, 2026, Recent Developments in Orange Book Litigation: How Patent Disputes Shape Prescription Drug Affordability ONeill Institute for National and Global Health Law, accessed February 26, 2026, Intricacies of the 30-Month Stay in Pharmaceutical Patent Cases | Articles Finnegan, accessed February 26, 2026, To Be Listable in the FDAs Orange Book, Patents Must Recite the API in Claims, accessed February 26, 2026, The Uncoupling of Device and Drug: A Strategic Post-Mortem of Teva v
Privacy Hims uses an encrypted data platform to keep user information private
A science-backed supplement bundle designed to support women on, or transitioning off, GLP-1 medications by helping to maintain skin and muscle health as they are impacted during rapid weight loss